MKM Partners analyst Bill Kirk lowered the firm’s price target on Tilray to $3 from $4 and keeps a Neutral rating on the shares. The company’s Q2 marked the smallest net sales quarter since its merger with Aphria, and catalysts for operational improvement are "unclear", the analyst tells investors in a research note. Kirk adds that while Tilray’s adjusted gross margin was "flat" and its distribution saw an expansion of 200bps, the management’s goal of $70M-$80M in adjusted EBITDA for FY23 is "risky".
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly
See the top stocks recommended by analysts >>
Read More on TLRY: